Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Testicular Neoplasms 1Teratoma 1Sarcoma 1Papillomavirus Infections 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Ototoxicity 1Osteosarcoma 1Neuroblastoma 1Medulloblastoma 1Liver Neoplasms 1Hepatoblastoma 1HIV Infections 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Etoposide 5Filgrastim 4Cisplatin 4Bleomycin 4Paclitaxel 3Ifosfamide 3Taxes 2Polymerase Chain Reaction 2Granulocyte Colony-Stimulating Factor 2Gene Expression Profiling 2Carboplatin 2sodium thiosulfate 1liposomal amphotericin B 1Thrombopoietin 1Surgical Procedures, Operative 1Reverse Transcriptase Polymerase Chain Reaction 1Restraint, Physical 1Psychiatric Rehabilitation 1Peripheral Blood Stem Cell Transplantation 1Nicotine 1Immunohistochemistry 1Gemcitabine 1Electroacupuncture 1Docetaxel 1DNA Methylation 1Congresses as Topic 1Caspofungin 1Base Sequence 1Amplified Fragment Length Polymorphism Analysis 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Testicular Neoplasms × Restraint, Physical × Clear all
NCT00716976 2023-11-09

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Children's Oncology Group

Phase 3 Completed
131 enrolled 18 charts 1 FDA
CNSGastrointestinalGenitourinaryGynecologicSarcoma

Ovarian Germ Cell Cancer, Ototoxicity, Brain Neoplasms, Liver Neoplasms, Medulloblastoma, Neuroblastoma, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡